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Caveolin expression supports the multiplication of retro-, ortho- and paramyxoviruses in susceptible
cells. However, human inﬂuenza A virus (IAV), an orthomyxovirus, does not multiply efﬁciently in mouse
embryo ﬁbroblasts (MEFs), which are abundant in caveolin-1 (Cav-1). Surprisingly, the absence of Cav-1
in a MEF cell line removed the block for IAV replication and raised the infectious titer 250-fold, whereas
the re-introduction of Cav-1 reversed the effect. The monitoring of cellular pathways revealed that Cav-1
loss considerably increased activities of p53. Furthermore, infection of MEF Cav-1 (/) induced
reactive oxygen species (ROS) and pronounced apoptosis in the late phase of viral multiplication, but no
type I IFN response. Strikingly, pharmacological inactivation showed that the elevated levels of ROS
together with apoptosis caused the increase of virus yield. Thus, Cav-1 represents a new negative
regulator of IAV infection in MEF that diminishes IAV infectious titer by controlling virus-supportive
pathways.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Viral growth limitations give valuable insights into pro- and
antiviral mechanisms, as they are often caused by the presence or
induction of intracellular restriction factors or the absence of
cellular dependency factors necessary for efﬁcient virus multi-
plication. Moreover, the type and density of viral surface receptors
and the effectiveness of induced antiviral defense mechanisms are
reasons for differences in susceptibility to virus infection (Chin and
Brass, 2012; Garcia-Sastre et al., 1998; Koerner et al., 2007; Ma et al.,
2011; Seitz et al., 2010; Wang et al., 2007, 2014).
Bronchial/tracheal epithelial cells are the primary target of
human inﬂuenza A virus (IAV) infection. Compared with the main
target cells, other cell types exhibit lower permissiveness for
inﬂuenza virus replication. For example, adjacent immune cells
such as macrophages can be productively infected, albeit to a
lower extent (Manicassamy et al., 2010). Moreover, virus restric-
tion has been found in human mast cells, from which fewer
viruses are released compared with other permissive cell lines
(Marcet et al., 2012). Furthermore, mouse ﬁbroblasts only weakly
support the replication of human inﬂuenza viruses and it has been
suggested that viral replication is aborted at a nuclear stage in
infected cells (Garcia-Sastre et al., 1998).
Inﬂuenza virus multiplication depends on components of the
host machinery. For efﬁcient infection and dissemination in tissue,
the inﬂuenza hemagglutinin protein (HA) must be cleaved into its
subunits by cellular proteases (Böttcher-Friebertshäuser et al.,
2012; Böttcher et al., 2006; Garten and Klenk, 2008). IAVs enter
the cell via receptor-mediated endocytosis and a second non-
caveolar entry mechanism (Lakadamyali et al., 2004). The entry is
dependent on the type of the receptor determinant: human
inﬂuenza viruses prefer binding to α2,6-linked neuraminic acid
residues present on glycoproteins and glycolipids, whereas avian
inﬂuenza viruses use α-2,3-conjugated neuraminic acids for entry.
A V-type ATPase, a proton-transporting enzyme that functions in
acidiﬁcation and fusion, has been identiﬁed as a host factor in
genome-wide screening based on RNA interference (Chin and
Brass, 2012; Watanabe et al., 2010). Inﬂuenza particles enter the
nucleus in a manner dependent on members of the importin
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family (Gabriel et al., 2008, 2011). Nuclear export is also depen-
dent on active and passive mechanisms to aid the timely export of
newly synthesized vRNP (viral ribonucleoprotein) to the plasma
membrane. In particular, the active nuclear export of vRNPs is
triggered by HA accumulation at the plasma membrane followed
by activation of the MEK (also known as mitogen-activated protein
kinase kinase)/extracellular signal-regulated kinase (ERK) pathway
(Marjuki et al., 2006). The concerted apoptosis in the late phase of
viral replication then increases the accumulation of vRNP in the
cytoplasm through nuclear pore widening by caspase 3 action
(Wurzer et al., 2003, 2004). This is remarkable, since, in the past,
both apoptosis and formation of reactive oxygen species (ROS)
have been considered to limit replication and the spread of
viruses. Lately, however, virus-supportive effects have been
increasingly observed for both mechanisms (Bottero et al., 2013;
Herold et al., 2012; Wurzer et al., 2003). Apart from the contribu-
tion of actin and Rab11 to ﬁlamentous virus budding (Bruce et al.,
2010) and the involvement of RACK1 (receptor for activated C
kinase 1), few other determinants are needed for the assembly and
release of IAVs. Inﬂuenza viruses require the crosstalk of cellular
RACK1 protein with its M1 protein for release (Demirov et al.,
2012), and they apparently do not rely on ESCRT-mediated exit
(endosomal sorting complexes required for transport) (Bruce et al.,
2009; Chen and Lamb, 2008; Goettlinger, 2010; Rossman et al.,
2010; Rossman and Lamb, 2011). Strikingly, ﬁlamentous inﬂuenza
virus pinching-off is dependent on the M2 protein, which solely
makes use of a short amphipathic helix in M2 to induce curvature
and subsequent scission of the budding virus (Rossman et al.,
2010).
In our investigation, we have analyzed the role of Cav-1 in
human IAV infection of mouse ﬁbroblasts. Cav-1 is a lipid-raft-
resident protein involved in caveolae formation, cellular signaling,
and cholesterol transport and its homeostasis (Liu et al., 2002). In
general, Cav-1 modulates virus propagation by interaction with
various viral proteins (Brown et al., 2002; Hovanessian et al., 2004;
Huang et al., 2007; Mir et al., 2007; Parr et al., 2006; Ravid et al.,
2010; Sun et al., 2010; Yu et al., 2006; Zou et al., 2009). Several
binding regions have been described (Ball et al., 2013; Hovanessian
et al., 2004; Huang et al., 2007; Ravid et al., 2010; Sun et al., 2010).
Intriguingly, Ravid et al. (2010) have demonstrated that Cav-1
binds to the viral M protein of parainﬂuenza virus (PIV5), a para-
myxovirus, through a deﬁned caveolin-binding motif (CBM),
and that the protein is important for assembly and budding.
Recently, Cav-1 has also been shown to be able positively to
modulate the propagation of IAV in Madin–Darby canine kidney
(MDCK) cells (Sun et al., 2010), presumably by binding to M2 (Sun
et al., 2010; Zou et al., 2009). In addition to the structural support
of Cav-1 in the transport and localization of foreign proteins to
lipid rafts, its involvement in signaling has gained much interest
over the last few years (for reviews, see Boscher and Nabi (2012)
and Liu et al. (2002)). Thereby, Cav-1 serves as a scaffold to
organize signaling-competent complexes in lipid rafts and caveo-
lae (Liu et al., 2002).
Here, we report that the Cav-1 depletion in mouse ﬁbroblasts
results in a 250-fold increase in the yield of infectious human
inﬂuenza A (H1N1) virus. Reporter gene arrays and biochemical
assays have revealed that the infection of Cav-1-depleted mouse
embryo ﬁbroblast (MEF) cells with IAV PR/8/34 severely induces
stress/toxicity response mechanisms. Results from inhibition
experiments have shown that the timely induction of apoptosis
and the appearance of ROS particularly cause a considerable
increase in the production of infectious virus. Furthermore,
whereas a low activity of transcription factors responsible for
the expression of type-I-interferon-stimulated genes is observed
upon H1N1 infection of MEF wildtypes (MEF WT), such a response
is absent in PR8-infected MEF Cav-1 (/) cells. Thus, the
stress/toxicity response and, presumably, the impairment of com-
ponents of the innate immune response contribute to increased
virus production.
Results
MEFs yield increased infectious titer in the absence of Cav-1
Mouse ﬁbroblasts exhibit a low permissiveness for the propa-
gation of human IAV (Garcia-Sastre et al., 1998). Usually, infectious
titers have been reported that are 3–4 orders of magnitude lower
than titers from permissive cell lines such as MDCK (Garcia-Sastre
et al., 1998). To investigate the inﬂuence of Cav-1, which supports
retrovirus, paramyxovirus, and orthomyxovirus replication in
permissive cell lines (Hovanessian et al., 2004; Huang et al.,
2007; Ravid et al., 2010; Sun et al., 2010; Yu et al., 2006; Zou et
al., 2009), we investigated the effect of Cav-1 loss on human
inﬂuenza virus production in a Cav-1-deﬁcient MEF ﬁbroblast line
(3T3 MEF KO also refered to as MEF Cav-1 (/), ATCC CRL 2753)
derived from a Cav-1 knock-out mouse (Razani and Lisanti, 2001).
For this purpose 3T3 MEF KO were infected with A/PR/8/1934 at a
multiplicity of infection (MOI) of 0.5 for 1 h, and infectious virus
titers were determined 24 h post-infection by plaque assay on
MDCK and compared with the titers achieved by the parental cell
line (3T3 MEF WT, ATCC CRL 2572) (Fig. 1). Intriguingly, a 250-fold
increase could be observed, on average, in the speciﬁc productivity
of infectious virus in the absence of Cav-1.
To exclude that selected cell populations arising during the
establishment of the Cav-1 KO cell line could contribute to the
increase in virus production, we performed Cav-1 knock-down
experiments with IAV infected 3T3 MEF WT cells (Fig. 2A). For this
purpose, retroviral transduction was used to introduce a Cav-1
shRNAi into MEF WT and to select for integration events yielding
MEF KD Cav-1 as described earlier (Schuck et al., 2004; Sun et al.,
2010). At 24 h after infection, IAV production from 3T3 MEF WT,
MEF KD Cav-1, and MEF transduced with the empty retroviral
vector was compared. On average, MEF KD Cav-1 cells yielded 2.7-
fold more infectious virus than 3T3 MEF cells. The transduction of
MEF wt MEF Cav-1 (-/-)
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Fig. 1. Effect of caveolin-1 depletion on human inﬂuenza A virus (H1N1) produc-
tion in mouse ﬁbroblasts. Mouse embryo ﬁbroblasts (MEF WT) and Cav-1 (/)
deﬁcient MEFs were infected with an MOI of 0.5 with inﬂuenza A virus (PR/8/1934)
for 1 h and incubated in production medium for 24 h. The titer of infectious virus
was determined from ﬁltered supernatants on MDCK cells by using a plaque assay.
Virus titers are given in plaque-forming units (pfu) per one million cells in a
production period of 1 day. Statistical analysis was performed by using the paired
t-test (n¼6, *po0.05). Inset: Western blot detection of Cav-1. The 24 kD signal
(α-form) is abundant in cell extracts from mouse embryo ﬁbroblasts 3T3 MEF WT
and NIH3T3, but is absent in MEF Cav-1 ( /).
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the empty retroviral vector (as a second control) had a negligible
inﬂuence on the infectious virus titer (data not shown). The
considerable increase in IAV infectious titers conﬁrmed that Cav-1
depletion rather than genomic abnormalities of the cell line was
responsible for the enhancement. However, compared with 3T3
MEF KO, the yield of infectious virus was lower than in MEF KD
Cav-1 cells; this might have been caused by incomplete removal of
Cav-1 in MEF KD Cav-1. Indeed, Western blots revealed that in
knock-down experiments, the Cav-1 level was reduced by 48% on
average (data not shown), which indicates that the gain of infec-
tious virus correlated with the degree of Cav-1 depletion.
To conﬁrm that Cav-1 impaired IAV propagation in MEF, we
probed a reversion of the phenotype by the re-introduction of a
Cav-1 cDNA into MEF Cav-1 double-knockouts in gene transfer
experiments (Fig. 2B). Western blots revealed that Cav-1 was
introduced successfully into MEF Cav-1 (/) (Fig. 2B bottom).
Despite only moderate transfection efﬁciency, Cav-1 re-expression
decreased infectious viral titers 3- to 5-fold compared with those
in the Cav-1-depleted cell line. The results showed that the re-
introduction of Cav-1 into MEF Cav-1 (/) reverted the pheno-
type, albeit only partially. These data taken together indicate that
Cav-1 is responsible for the considerable reduction in the amount
of infectious virus released from MEF.
Enhancement of virus production by Cav-1 loss in mouse
ﬁbroblasts was in clear contrast to the support of human IAV
replication by Cav-1 observed in MDCK cells and the contribution
to the production of PIV5 (a paramyxovirus) and of the mouse
leukemia virus (MLV), a γ-retrovirus, in NIH3T3 cells (Ravid et al.,
2010; Sun et al., 2010; Yu et al., 2006). Since human IAV targets
primarily human lung epithelial cells, and since mouse ﬁbroblasts
are an unusual host for human IAV, we tested the effect of Cav-1
KD on IAV production in A549, a human lung epithelial cancer cell
line (Fig. 3). Interestingly, IAV production in retrovirally Cav-1
RNAi transduced A549 did not change signiﬁcantly compared with
wildtype A549 or A549 transduced with the empty retroviral
vector, suggesting that interference with human IAV virus produc-
tion might correlate with a speciﬁc property of Cav-1 in this
cell line.
Reporter gene assays identiﬁed pathways in MEF affected by Cav-1
loss and IAV infection
We hypothesized that Cav-1 either might directly interfere with a
viral component or might modulate one or more cellular pathways
important for virus propagation or antiviral defense. To address the
question for the interaction with cellular pathways, a search was
performed for signaling pathways that were affected through Cav-1
loss and IAV infection in MEF cells. For this purpose, we used the
Cignal 45-Pathway Reporter Gene Array-Kit (SA Biosciences, Qia-
gen), which is a cell-based reporter array for identifying multiple
signaling pathways in cultured cells by monitoring the alteration in
activity of 45 transcription factors upon treatment. The activity
signature obtained can be used to deﬁne which out of ten cellular
conditions or responses is elicited by the treatment, e.g., immune
response, cancer, oxidative stress, or apoptosis. All assays were
performed 3-fold in independent experiments, and each experiment
in duplicate. Values from positive and negative control vectors
co-processed in triplicate in each of the arrays were used for the
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Fig. 2. Effect of caveolin-1 knock-down and knock-in on human inﬂuenza A virus
(H1N1) production in mouse ﬁbroblasts. A. Cav-1 was down-modulated by RNAi by
using retroviral transfer of pRVH1Cav-1 into 3T3 MEFWT and antibiotic selection of
transduced cell clones. Knock-down cells and wildtype MEF were infected with IAV,
and virus infectious titers were determined 24 h after infection. For a better
comparison, the relative titers are given. These titers were calculated from the
volumetric productivity (pfu/ml); data are derived from three independent experi-
ments. Error bar: standard deviation. B. MEF Cav-1 (/) were transiently
transfected with pCav1 WT. At 24 h after transfection, cells were infected with
PR8 virus for 1 h, and 24 h later, titers were determined from ﬁltered supernatants
with the help of a plaque assay. Relative infectious titers of two independent
experiments are shown. Transfection efﬁciencies were analyzed separately and
usually ranged between 10% and 30%. KO: MEF Cav-1 (/); KI: MEF knock-in
resulting from transfection of MEF KO.
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Fig. 3. The effect of Cav-1 knock-down on virus titer in an IAV-infected lung
epithelial cell line. Knock-down of Cav-1 in A549 cells was performed by retroviral
transduction as described earlier. Wildtype A549, Cav-1 knock-down A549, and
A549 transduced with the empty retroviral vector were infected with IAV at an
MOI¼1 and compared with respect to the release of inﬂuenza viruses. For
comparison, 3T3 MEF WT and MEF Cav-1( /) were equally treated. Particle
titers were determined 24 h after infection with the luminometric neuraminidase
assay (NA STAR). Data are from two independent experiments. Error bars represent
the standard deviations.
K. Bohm et al. / Virology 462-463 (2014) 241–253 243
statistical analysis according a published procedure (Cumming et al.,
2007). As a result of the statistical analysis, activity changes of 41.7
fold were regarded as signiﬁcant with po0.05 at n¼3. Furthermore,
to account for dispersion of transcription factor activities in indivi-
dual reporter assays, p-values were calculated from several samples
by using an unpaired t-test (Supplementary Table 2).
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First, to elucidate the effect of the depletion of Cav-1 on
ﬁbroblast physiology, we compared MEF Cav-1 (/) and MEF
WT cells and screened for changes in transcription factor activities
(KO/WT, ﬁrst column in Fig. 4). As expected, several pathways in
MEF were affected by the loss of Cav-1. In particular, the absence of
Cav-1 caused a 3.2-fold increase of p53 activity and a 2.5-fold
increase of RBP-Jk activity. p53 regulates the cell cycle and is
regarded as a genome guardian mainly activated by DNA damage.
RBP-Jk is a key factor in the Notch signaling pathway, a regulatory
pathway in development that determines cell fate. Furthermore, a
distinct MAP-kinase pathway, the MEK/ERK pathway, was down-
regulated 6-fold, as indicated by the SRE-(serum response element)
reporter activity. The anti-oxidant response (nuclear erythroid p45
related factor 2 (NRF2), 0.4-fold activity), androgen response
element (AR, 0.3), amino acid synthesis (AARE, 0.4), and liver X
reporter (LXR 0.3) showed more than 2-fold diminutions of their
activity compared with MEF WT.
Similarly, the stimulus of human inﬂuenza virus PR8 infection on
MEFWT (Fig. 4 column 3, WT i/WT) and Cav-1 (/) cells (column
4, KO i/KO) was elucidated in separate experiments. Since the
reversely transfected MEFs were rapidly lost at infection periods
of 45 h, cells were analyzed at 4 h after infection, thereby
monitoring cellular events induced by early and delayed-early IAV
replication. The activity of nuclear factor kappa-B (NF-κB), which is
well-known for its immune-modulating effects, increased 3.2-fold
upon infection of Cav-1 (/) and 4-fold upon infection of MEF
WT. Intriguingly, antioxidant response was induced 2-fold, but only
in Cav-1-deﬁcient cells, similar to the protein kinase C (PKC)/Ca2þ
pathway as indicated by NFAT activity (nuclear factor of activated T
cells, NFAT, 2.5). Similarly, the MEK/ERK pathway, which had been
down-regulated 6-fold in Cav-1-depleted MEF, now exhibited a
2.3-fold increase in activity (SRE, 2.3). The interferon-β response
(ISRE reporter) was induced 2-fold upon PR8 infection only in WT
cells, whereas such a response was missing in Cav-1-depleted
infected MEFs. These ﬁndings suggest a perturbation either in the
early or late phase of the type I interferon pathway, which is
initiated by the absence of Cav-1. When these data are taken
together, the signatures of the transcription factors mainly suggest
a response of Cav-1-depleted IAV-infected cells that is typical for
stress/toxicity conditions, regulatory alterations noted in cancer
development, or cell differentiation, and that includes a minor,
but distinct contribution of regulators of the immune response.
p53 induction is caused by Cav-1 depletion
Next, we had to exclude that a mutant p53 protein could account
for the observed p53 activity in Cav-1-depleted 3T3 MEF WT, an
effect that might result from a selected cell population that has
been generated during the process of the establishment of the
immortalized MEF Cav-1(/) double knock-out cells. For this
purpose, we transfected pCav-1WT, a Cav-1 expression vector, into
MEF Cav-1 (/) cells together with a p53 reporter plasmid or a
control vector and determined the luciferase activity by using the
LAR assay (Promega). The p53 reporter pPG13 Luc contains repeated
consensus binding sites for the activated transcription factor p53
followed by a ﬁreﬂy luciferase reporter gene; pMG15 Luc harbors an
iterated mutant p53 binding site and serves as negative control
(El-Deiry et al., 1993). The assay is reliable, leading to 3–8 fold
reduction of Luc activity when mutant binding site reporter is used
(Fig. 5 cf. 1, 2 and also 3, 5). Fig. 5 shows that the Cav-1 absence
results in an increase of at least 6-fold in p53 activity (cf. lanes 1 and
3). Furthermore, re-introduction of Cav-1 into the Cav-1-deﬁcient
ﬁbroblasts reduces p53 activity to nearly the same level as that
observed in the wildtype MEF cell line (cf. lane 3 and lane 5). This
clearly demonstrates that p53 activation is not the result of aberrant
genomic properties of MEF Cav-1 (/) but is indeed caused by
the Cav-1 deletion in these mouse embryo ﬁbroblasts.
Apoptosis is induced in H1N1-infected Cav-1-deﬁcient MEFs and
contributes to the increase in infectious virus titer
To gain more insight into the factors that cause the limitation of
IAV production in MEF, we analyzed members of the stress/toxicity
proﬁle in more detail. Surprisingly, several factors affected by
Cav-1 loss in conjunction with the PR8 infection are involved in
the regulation of programmed cell death (p53, NF-κB, antioxidant
response to ROS formation, MEK/ERK). To conﬁrm that infected
MEF Cav-1 (/) had undergone programmed cell death, we used
two ﬂuorescent apoptosis assays to compare the state of infected
and mock-infected WT and Cav-1-deﬁcient MEFs. First, a combined
Annexin-V/propidium iodide/Hoechst 33342 staining together with
a quantitative image analysis was applied to determine the number
and percentage of apoptotic and necrotic cells in PR8-infected and
mock-infected MEFs (Fig. 6). At 4 h after infection, apoptosis was
slightly increased only in infected MEF WT cells, whereas infected
Cav-1-deﬁcient MEFs exhibited only low levels of apoptosis induc-
tion. However, at 16 h after infection, the degree of apoptosis was
increased considerably in infected Cav-1-depleted MEFs with 10-fold
more cells entering programmed cell death than in mock-infected
MEF WT. Interestingly, the mock-infection procedure (by using
phosphate-buffered saline (PBS) supplemented with trypsin 1 mg/ml
andMg2þ/Ca2þ) slightly affected the number of apoptotic cells in MEF
Cav-1 (/) indicating a sensitization (preconditioning) of cells to
apoptosis upon Cav-1 loss.
To complement the results of the Annexin V assay, a ﬂuorescent
assay monitoring caspase 3/7 activity was applied in a further set
of experiments in cells infected for 4, 16, and 24 h (Fig. 7). A low
level of effector caspase activity was found in mock-infected and
infected MEFWT at all times investigated. However, a considerable
boost of activity was noted in infected MEF Cav-1 (/) after
24 h. On average, 8% of the total cell moiety exhibited caspase 3/7
activity. These data conﬁrm the previous results showing that
apoptosis is markedly increased exclusively in Cav-1-deﬁcient MEF
in the late phase of inﬂuenza virus infection and dissemination.
To establish that apoptosis is responsible for the increase in
infectious inﬂuenza titer in MEFs lacking Cav-1, the effect of
caspase 3/7 inhibition on virus yield was investigated. For this
purpose, SC-3074 (Santa Cruz Biotechnology), a cell-permeable
Fig. 4. Activity proﬁles of transcription factors in MEF upon Cav-1 loss and infection with inﬂuenza A virus PR8. Heat-map of activity changes of transcription factors derived
from Cignal ﬁnder 45-pathway reporter gene arrays. The average fold changes in the activities (treated/untreated) are depicted in four columns (red, active; blue, inhibited;
white no change compared with the untreated control). From left to right, column 1 KO/WT: comparison of MEF Cav-1 (/) and 3T3 MEF WT; column 2: comparison of
MEF Cav-1 (/) and MEF WT both infected; column 3: comparison of infected with mock-infected 3T3 MEF WT; column 4: comparison of infected and mock-infected MEF
Cav-1 (/). The array contains expression plasmids that harbor speciﬁc promoters indicating changes in the activity status of 45 transcription factors together with control
and normalizing plasmids. 3T3 MEF WT and MEF Cav-1 ( /) cells were reversely transfected onto a 96 well Cignal ﬁnder 45er reporter gene array, which contains the
reporter plasmids spotted in duplicate. Infections were performed with 0.5 MOI of PR8 virus for 1 h, and cells were incubated for an additional 4 h in complete medium.
Activities were determined by using the Dual Luciferase Reporter assay. Relative changes (averaged from three independent experiments) were calculated from normalized
ﬁreﬂy luciferase values and represent the degree of transcription factor activity. For abbreviations see the information on the internet page of the provider (www.
sabiosciences.com/reporter_assay_product/HTML/CCA-901L.html). For statistical assessment, standard errors were calculated. Average values were derived from the
evaluation of three independent experiments and duplicates in each experiment. Evaluation of the control datasets showed that a 1.7-fold increase of average values upon
stimulus was sufﬁcient to give a p-value of o0.05 at n¼3, indicating the threshold for test values to be derived from an independent moiety with a 95% probability.
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peptide inhibitor of caspases 3, 6, 7, 8, and 10 was added at two
different concentrations. Fig. 8 shows that incubation with 1 and
5 mg/ml inhibitor prior to infection was sufﬁcient to reduce caspase
3/7 activity 3- and 10-fold, respectively. Subsequently, the viral
load was determined by a luminescent neuraminidase assay,
which is equivalent to the hemagglutination assay for indicating
viral particle numbers (Buxton et al., 2000; Kalbfuss et al., 2008;
Nayak and Reichl, 2004). In the presence of the inhibitor, the
relative particle numbers decreased only slightly, whereas plaque
assays revealed that only half of the infectious inﬂuenza virus was
released from infected Cav-1-deﬁcient cells compared with
infected parental MEFs. Thus, apoptosis in the late phase of virus
infection of MEF Cav-1 (/) contributes to the boost in infec-
tious virus observed in this cell line.
Finally, to exclude cell abnormalities as being the cause for
apoptosis induction by late IAV infected MEF KO Cav-1 and to
establish that Cav-1 depletion was causative for the increase of
apoptosis, we transiently re-introduced Cav-1 into MEF KO Cav-1
and investigated the effect on apoptosis upon IAV infection
(Supplementary Fig. 1). The portion of apoptotic cells in the total
cell number was determined 19 h after infection by using pSIVA-
IANBD (an Annexin XII binding dye that monitors the membrane
exposure of phospatidyl serine) and PI (propidium iodide, for
determination of necrotic cell numbers). pSIVA apoptosis was
found to be increased two-fold upon infection of Cav-1 deﬁcient
MEF compared with wildtype MEF (cf. col 1 and 2), which
supports data derived initially by Annexin V staining (Fig. 7).
Actually, in the MEF Cav-1 knock-in cells (MEF KO KI PR8), the
percentage of apoptotic cells declined 1.7-fold. Thus, the loss of
Cav-1 in MEF KO Cav-1 is causative for the rise of apoptosis in IAV
infected cells.
Antioxidant response results from increase of the ROS level in infected
Cav-1-deﬁcient MEFs
ROS can arise as side-product of the respiratory chain. High ROS
levels have to be removed, since they are detrimental to cells and
result in apoptosis. The formation of ROS at intermediate concen-
trations is a response of macrophages and neutrophils to microbial
invasion. Interestingly, at low concentrations, certain ROS serve
as a second messenger in cellular signaling. When infected (Fig. 4
ARE column 4) and mock-infected (Fig. 4 ARE column 1) MEF
Cav-1 (/) were compared, the reporter array indicated, in total,
a 5-fold raised activity of Nrf2 key regulator. The Nrf2 activity
predicts a considerable antioxidant response upon infection,
which is probably evoked by the generation of ROS. Strikingly,
the parental MEFs do not exhibit such an antioxidant response
under these conditions. To conﬁrm ROS generation, ROS levels
were determined by using a ROS sensor, namely the cell-permeable
CellROX™ Deep Red reagent (Invitrogen), which is non-ﬂuorescent
under normal conditions. However, upon oxidation by ROS, this
reagent exhibits a bright near-infrared ﬂuorescence that serves as a
direct measurement of the ROS level in live cells. Remarkably, on
average, 65% of the infected MEF Cav-1 (/) cells exhibited the
presence of ROS (Fig. 9). Thus, a marked level of oxidative stress was
apparent in infected Cav-1 (/) ﬁbroblasts, whereas only a
marginal ROS level was observed in infected MEF WT.
Inhibition of ROS diminishes infectious titers
The redox status of a cell is determined by the concentrations
of the cellular antioxidant glutathione and its oxidative form
(GSSG). Therefore, we assumed that a low GSH level or an altered
GSH/GSSG ratio might account for the abundance of ROS in IAV
MEF Cav-1 KO. Determination of the GSH and GSSH levels in
Fig. 6. Kinetics of apoptosis/necrosis in H1N1 virus-infected WT and Cav-1-
deﬁcient MEF cells. 3T3 MEF WT and MEF Cav-1(/) were infected with human
IAV PR8 at an MOI of 0.5 for 1 h followed by incubation with complete medium for
4 h (top) and 16 h (bottom). At the indicated times, cells were stained with Annexin
V FlUOS/propidium iodide/Hoechst 33342 and photographed by using an Axiovert
T135V ﬂuorescence microscope equipped with a digital camera (Zeiss). The
percentage of apoptotic/necrotic cells was determined by image analysis of multi-
ple pictures by using Image J.
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Fig. 5. Cav-1 loss in MEF cells activates p53. The p53 activation was determined by
a reporter gene assay 24 h after transfection of reporter gene plasmids carrying
either a promoter with reiterated p53 consensus binding sites (pPG13LUC) or
mutant binding sites (pMG15LUC, as a control) and luminometric detection of
ﬁreﬂy luciferase activity (F-Luc). 1, MEF WT transfected with p53 reporter plasmid
pPG13Luc; 2, MEF WT transfected with pMG15LUC (control); 3 MEF Cav-1 KO
transfected with p53 reporter pPG13LUC; 4 knock-in: MEF Cav-1KO and p53
reporter plus pCAV-1 WT; 5 MEF KO and p53 mutant reporter pMG15LUC. Blue
bars, 3T3 MEF WT; Red bars MEF Cav-1( /). Error bars represent the standard
error of the mean. Values were derived from four independent experiments; each
experiment was performed in quadruplicate.
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infected, knock-out, and wildtype ﬁbroblasts revealed that the
GSH/GSSG ratio was altered only marginally (Fig. 10). Surprisingly,
the GSH level in infected knock-out MEF was 4-fold lower than
that found in the respective experiment with wildtype MEF.
To conﬁrm the link between a low glutathione level, increased
ROS and infectious titer, administration of N-acetyl cysteine (NAC),
which replenishes the store of the antioxidant glutathione, was
performed. Pre-incubation with 0.1 and 1 mM NAC reduced the
ROS-level 2- and 10-fold in infected Cav-1-deﬁcient MEFs, respec-
tively (Fig. 10). Concomitantly, the infectious virus titer dropped
2.5-fold in infected MEF Cav-1 (/). The data show that ROS
contribute to the increase in titer in MEF Cav-1 (/), irrespec-
tively of the mechanism that is responsible for ROS-support in the
inﬂuenza virus life cycle.
Cav-1 depletion is causative for oxidative stress in inﬂuenzavirus-
infected MEF
Lastly, a knock-in experiment was performed to establish that
Cav-1 loss is responsible for the sensitivity to oxidative stress in
MEF KO Cav-1 infected with IAV. For this purpose, the ratio of
ROS-exhibiting cells was determined by CellROX Orange, 18 h
post-inﬂuenzavirus infection of pCAV1 WT transfected cells
(Supplementary Fig. 2) Remarkably, reactive oxygen species
declined 3-fold and reached a level that was found in infected
wildtype MEF. Thus, the reconstitution of the ROS level by Cav-1
re-introduction suggests that the Cav-1 presence in the mouse
embryo ﬁbroblast cell line controls the sensitivity to oxidative
stress in infected MEF.
Discussion
Cellular pathways linked to the block in IAV replication in MEFs
To a great extent, susceptibility to virus infection relies on the
effectiveness of antiviral defense mechanisms and/or the presence
of restriction factors in the individual cell type. Basically, the
degree of type I interferon response delimitates IAV multiplication
due to the expression of antiviral genes (Mx, PKR, OAse, IFITM,
viperin) (Chin and Brass, 2012; Garcia-Sastre et al., 1998; Koerner
et al., 2007; Wang et al., 2007). Intriguingly, the speciﬁcity of the
ﬁrst-line defense accounts for the effectiveness of the antiviral
response (Seitz et al., 2010; Staeheli et al., 1988). Recently, addi-
tional cellular components have been identiﬁed to counteract with
IAV multiplication by different mechanisms (Di Pietro et al., 2013;
Fig. 8. Inﬂuence of caspase-3 inhibition on inﬂuenza A virus particle and infectious titers in MEF Cav-1 (/). The MEF Cav-1 (/) cell line was pretreated for 1 h with
SC-3074, a cell-permeable inhibitor of caspase 3. Cells were infected with human inﬂuenza virus for 1 h followed by incubation in production medium for 24 h in the
presence of inhibitor. Left: effect of various inhibitor concentrations on caspase 3 activity. Right: effect of caspase inhibition on the relative number of viral particles
(as determined by a luminescent neuraminidase assay and depicting the NA activity as light units normalized to one million cells per day) and the number of infectious
viruses (determined by plaque assay).
Fig. 7. Course of caspase 3/7 activation in infected MEF cells. MEF WT and MEF Cav-1( /) were infected with human PR8 virus at an MOI of 0.5 for 1 h followed by
incubation with complete medium for 4, 16, and 24 h. At the indicated times, cells were treated by using a ﬂuorescent Caspase 3/7 assay and propidium iodide/Hoechst
33342 and photographed by using a Axiovert T135V microscope equipped with a digital camera (Zeiss). The percentage of apoptotic/necrotic cells was determined by image
analysis of multiple pictures by Image J. Error bars: standard deviation (SD).
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Wang et al., 2011, 2014; Watanabe et al., 2011). For example,
Annexin 6 negatively regulates inﬂuenza A virus replication by
impairing the release of progeny virus (Ma et al., 2011). Further-
more, heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1)
plays an inhibitory role in the viral life cycle through suppression of
NS1 protein levels and nucleocytoplasmic translocation of its mRNA
(Wang et al., 2014).
We have hypothesized that the low permissiveness of mouse
ﬁbroblasts for IAV replication might be attributable to a cellular
block(s) at an as yet unknown stage in the viral life cycle, an
instance that should provide insights into antiviral defense
mechanisms and cellular dependency factors (Ehrhardt et al.,
2010; Watanabe et al., 2010). In this investigation, we have
demonstrated that MEFs considerably increase their permissive-
ness for human H1N1 infection upon the deletion of caveolin-1,
a multifaceted membrane protein involved in cellular signaling
and the crossing of membrane barriers (Boscher and Nabi, 2012;
Liu et al., 2002), since Cav-1-deﬁcient MEFs release 250-fold more
infectious IAV on average compared with mock-infected MEF WT.
The Cav-1 loss considerably activates p53 and RBP-Jk, which are
key regulators in DNA damage/apoptosis and Notch signaling,
respectively, and which predispose cells for stress/toxicity-induced
mechanisms. Subsequent infection with H1N1 virus preferentially
activated stress response/toxicity mechanisms in the cell line,
including the NF-κB pathway, ROS generation, and apoptosis
induction. The data have also revealed that the loss of Cav-1
impairs the type I interferon response in MEFs. Subsequently,
selected biochemical assays and the use of pharmacological
inhibitors have provided evidence that the ROS generation/anti-
oxidant response and apoptosis induction considerably support
virus propagation in Cav-1-depleted MEFs. Together with a
presumably impaired type I interferon response, these factors
contribute substantially to the observed increase in infectious
virus titers in MEF Cav-1 (/) cells.
Infected MEF Cav-1 ( /) resemble human A549 lung epithelial cells
during apoptosis
Previously regarded as a host defense mechanism upon virus
infection, the view on apoptosis changed over the last decade,
when it became obvious that viruses can take advantage of
apoptotic signaling to support their own replication. In Cav-1-
depleted IAV-infected MEFs, apoptosis is extraordinarily raised late
in virus propagation and dissemination but is low in the initial
phase of infection (Figs. 5 and 6 Annexin V and Caspase 3/7
quantiﬁcation). Intriguingly, the kinetics of apoptosis induction in
these cells resembles the course of apoptosis in human lung
epithelial A549 cells infected with human IAV (Supplementary
Table 1), which is beneﬁcial for IAV multiplication (reviewed in
Herold et al. (2012)). In A549, apoptosis is blocked in the early
phase of inﬂuenza virus infection through the activation of the
PI3K/Akt pathway, a pro-survival cellular route; therefore, the
virus can multiply in an undisturbed manner (Ehrhardt et al.,
2007). However, late in infection, when surface glycoproteins
accumulate at the plasma membrane and vRNPs in the nucleus,
NF-κB activation then results in an increase in FAS ligand/tumor
necrosis factor-related apoptosis inducing ligand (TRAIL) expres-
sion. This in turn induces apoptosis and effector caspase-3 activa-
tion (Herold et al., 2012; Wurzer et al., 2004). Caspase-3 targets
several nuclear pore proteins and lamin and increases the diffu-
sion limit for vRNP complexes accumulated in the nucleus, thereby
resulting in improved vRNP release from the nucleus and
Cell type Percentage of ROS-positive cells
Mock + PR8 IAV
MEF wt 0 % 0.1 %
MEF Cav-1 (-/-) 0 % 65 ± 10.05 %
Fig. 9. ROS formation in wildtype and Cav-1-deﬁcient MEF upon infection with human inﬂuenza A virus. Top: ROS levels were determined in 3T3 MEF WT and Cav-1-
deﬁcient cells at 24 h after PR8 infection by using a ROS sensor, the cell-permeable CellROX™ Deep Red reagent, and the determination of the number of cell nuclei by
Hoechst 33342 treatment. A typical result from a representative experiment is depicted. Bottom: image analysis averaged over three experiments revealed the percentage of
ROS-positive cells7SD.
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subsequent virus assembly at the plasma membrane (Kramer et
al., 2008; Wurzer et al., 2003). In line with these observations, the
inhibition of caspase3 has been shown to prevent nuclear release
and cytoplasmic vRNP accumulation (Wurzer et al., 2003). Promi-
nently, the rate of apoptosis is higher by an order of a magnitude
late in 3T3 MEF KO upon IAV infection, compared with that in
infected MEF WT. Since caspase-3 inhibition reduces apoptosis in
our experiments and at the same time decreases infectious titers
in MEF Cav-1 (/), the ﬁndings suggest a supportive role of
apoptosis for IAV multiplication in these cells. We assume that, in
infected MEF Cav-1 (/), elevated titers are also evoked by
caspase-mediated nuclear pore widening, which is followed by an
increase in the vRNP nuclear release late in virus multiplication. In
contrast to A549, apoptotic events are shifted to 16–24 h post-
infection, which might be attributable to the differing replication
rates of H1N1 virus in MEF. Furthermore, similar to infected A549
cells, apoptosis is blocked in the initial phase of infection. This
could allow IAV efﬁciently to multiply the viral components after
entry into the cell, as has been recently suggested for infected lung
cells. However, unlike in A549 cells, the activity of the PI3K/Akt, a
pro-survival pathway, is not altered in MEF Cav-1 (/) by IAV
infection. This ﬁnding points to a different pro-survival mechan-
isms in MEF Cav-1 KO post-infection.
Interestingly, p53 activation has been reported in inﬂuenza A
virus infected A549, which contributes to apoptosis in this cell line
and in MEF (Turpin et al., 2005). Strikingly, Cav-1 deﬁcient MEF
retains the increased p53 activity upon IAV infection, a circum-
stance that might also contribute to the apoptosis observed.
Furthermore, knock-down of Cav-1 in human lung endothelial
cells A549 did not result in a higher permissiveness to IAV
infection (Fig. 3), suggesting different impacts of Cav-1 reduction
in human lung epithelial cell line A549 compared with mouse
embryo ﬁbroblasts. In agreement with a cell-type speciﬁcity of
Cav-1 action, MDCK cells exhibited a lower IAV yield if Cav-1 was
diminished by RNAi (Sun et al., 2010). The reasons for these
differences are not clear as yet but might be connected to the
different cellular distributions and functions of Cav-1 in MEF
compared with the polarized MDCK and A549. Interestingly, in
MDCK and A549 cells, both the α- and β-form of Cav-1 are found
(Bélanger et al., 2003), whereas in mouse ﬁbroblasts, the α-form,
which is the slower migrating form in SDS-PAGE, prevails. In the
Cav-1 ß-form, amino-terminal residues are missing, which is
presumably caused by usage of an alternate start codon during
translation (Scherer et al., 1995). Thus, cell-type-speciﬁc effects
modulating the permissiveness for virus propagation might arise
from the presence of the different forms of Cav-1 or the intracel-
lular Cav-1 localization.
Presently, the factors that connect Cav-1 loss to the induction of
apoptosis in infected MEFs remain unknown. Nevertheless, links of
Cav-1 to apoptosis have been reported lately. In this respect, Cav-1
deﬁciency provokes cholesterol-dependent mitochondrial dys-
function and apoptotic susceptibility in MEFs (Bosch et al., 2011).
Furthermore, several lines of evidence indicate interactions of Cav-1
in the apoptosis/survival of cells (Rodriguez et al., 2009; Torres et al.,
2007; Zhang et al., 2011; Zou et al., 2012). Taken together, these
reports present multiple targets for Cav-1 in programmed cell death.
ROS/ARE contribute to increased production of infectious IAV in MEF
Cav-1 ( /)
Activity proﬁling has revealed a 4-fold increase in total in the
antioxidant response, as monitored by Nrf2 activity, a key reg-
ulator in the cellular response to ROS (Nguyen et al., 2009). ROS is
readily detectable in 65% of the cells by an ROS sensor assay at
1 day after the IAV infection of Cav-1-depleted MEFs but is absent
in the mock-infected control and occurred only marginally in
infected MEF cells. Furthermore, oxidative stress is caused by loss
of Cav-1 in infected MEF, since regaining Cav-1 expression through
transient transfer of a wild-type Cav-1 expression vector reduced
ROS to the level found in wildtype MEF. The level of glutathione, a
cellular antioxidant, is four-fold lower in MEF Cav-1(/) cells
compared to 3T3 MEF WT. Strikingly, inhibition by the ROS
scavenger N-acetyl cysteine (Geiler et al., 2010), a chemical com-
pound which replenishes the cellular glutathione level, markedly
decreases the production of infectious virus in our experiments. The
data suggest that the low level of glutathione or the presence of ROS
exerts a supportive effect on the production of infectious virus in
GSH/GSSG ratio
Exp. 1 Exp. 2
MEF WT 7,1 8,8
MEF Cav-1 KO 10,6 10,8
GSH ratio
Exp. 1 Exp. 2
MEF Cav-1 KO / WT 0,231 0,230
Fig. 10. Glutathione level and effect of ROS inhibition on infectious inﬂuenza virus
production in Cav-1-deﬁcient MEFs. A. Glutathione (GSH) and oxidized glutathione
(GSSG) levels were determined from equal numbers of 3T3 MEF WT and MEF Cav-1
(/) cells by using a luminometric GSH assay (GSH/GSSG-Glo Assay, Promega)
24 h after infection (MOI¼1) from two independent experiments performed in
duplicate The cellular GSH/GSSG ratios and the GSH ratio of MEF WT to MEF Cav-1
KO are shown. B. MEF Cav-1 (/) were pre-treated with the indicated concen-
trations of N-acetyl-cysteine (NAC), a ROS scavenger, and infected with human
inﬂuenza virus. ROS levels were determined by using the cell-permeable CellROX™
Deep Red Reagent in combination with Hoechst 33342 followed by quantitative
image analysis. Results were derived from at least two independent experiments. C.
Infectious virus titers upon inhibition.
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Cav-1-deﬁcient MEF, albeit through an as yet unknown mechanism.
Generally, ROS effects in biological systems depend on the concen-
tration and type of free radicals. For example, at a low level, nitric
oxide (NO), a free radical with moderate reactivity, serves as a
second messenger. Low levels of ROS also trigger an antioxidant
response via Nrf2 activation. Intermediate concentrations of ROS act
anti-microbially, e.g., kill bacteria that have been engulfed by
macrophages and elicit NF-κB activation. A high ROS level usually
causes apoptosis and thus is deleterious to animal cells. Presently,
without further experiments, much room exists for speculation
about which mechanism might be responsible for these outcomes.
Preliminary experiments have revealed that the emergence of ROS
in infected MEF Cav-1(/) does not correlate with apoptosis
induction and, thus, seemingly does not link caveolin-1 loss and
ROS formation to apoptosis (data not shown). This is in agreement
with a recent report showing that Cav-1 depletion uncouples
apoptosis from ROS in cells upon hyperoxia (Zhang et al., 2011). If
a ROS-mediated induction of apoptosis is presumably not involved
in increased permissiveness for human IAV, a more direct ROS
interaction with a cellular component or a mechanism modulating
inﬂuenza virus multiplication might be operated. In this respect, a
recent investigation demonstrating that ROS considerably contri-
butes to the infection of KSHV (Kaposi-sarcoma associated herpes
virus, HHV-8), a γ-herpes and double-stranded DNA virus, by
ampliﬁcation of signal transduction pathways affecting viral entry
(Bottero et al., 2013) is of interest. Furthermore, H202 promotes the
replication of HIV-1 in cell culture through NF-κB activation,
whereas antioxidants such as N-acetyl-cysteine have the opposite
effect (Roederer et al., 1990; Staal et al., 1990). Whereas the effects
of ROS induction by IAV in lung macrophages and its consequences
for lung tissues are well documented (summarized in Vlahos et al.
(2012)), reports about the direct effects of ROS formation on
inﬂuenza virus are rare. Recently, ROS inhibition has been observed
not only to prevent inﬂuenza-virus-infected A549 cells from injury
by free radicals, but also considerably to decreased IAV replication,
which strongly indicates a supportive role for ROS appearance in
inﬂuenza virus replication (Vlahos et al., 2011, 2012). Previously,
ROS assistance has also been linked to the inactivation of protease
inhibitors in lung tissue; this in turn favors the protease activation
of HA, a crucial step in inﬂuenza virus entry (Hennet et al., 1992).
Furthermore, ROS assistance might result from its counteracting the
endogenous cellular ROS scavenger glutathione (GSH), which has
been made responsible for a decrease in inﬂuenza virus replication
by reducing HA during synthesis and affecting correct protein
folding and thereby its function (Cai et al., 2003; Checconi et al.,
2013).
Presently, the exact mechanism, the type of ROS, and the
components that link Cav-1 loss to sensitization of MEF to
oxidative stress are unknown. However, recent investigations
indicate many contributions of Cav-1 in the regulation of the
anti-oxidant response and the generation of speciﬁc ROS in animal
cells (Felley-Bosco et al., 2000; García-Cardeña et al., 1997; Jin et
al., 2008; Li et al., 2012; Michel et al., 1997; Volonte and Galbiati,
2009). Thus, further experiments aimed at the identiﬁcation of the
ROS species involved and the characterization of the Cav-1 targets
in the antioxidant response and ROS generation will be required to
elucidate the link of Cav-1 loss/ROS abundance and inﬂuenza virus
titers and to exclude possible drug side-effects.
Contribution of other pathways to modulate inﬂuenza virus titers
Presently, additional pathways might account for the titer
increase in Cav-1-deﬁcient MEFs, e.g., the observed activation of
the MEK/ERK pathway (SRE reporter) or the impairment of type I
interferon response (Table 1). HA accumulation at the plasma
membrane has previously been shown to trigger MEK/ERK
signaling. MEK/ERK activation improves vRNP release from the
nucleus by increasing the NEP/CMR1-mediated support of the
active nuclear export mechanism (Marjuki et al., 2006; Pleschka et
al., 2001). A similar mechanism may account for the increase of
virus production in Cav-1-deﬁcient MEFs. Interestingly, Cav-1 has
been shown to inhibit activation of this pathway in mouse cells
(Engelman et al., 1998; Galbiati et al., 1998). Thus, it is conceivable
that upon the Cav-1 absence in MEFs this control is lost and that
the infection with IAV is sufﬁcient to trigger the activation of the
MEK/ERK pathway. This might be followed by an improved nuclear
export of vRNP and an increase in virus release.
NF-κB is well-known for its immune-modulating antimicrobial
functions. To a lesser extent, the transcriptional regulator is noted
for its supportive contribution to inﬂuenza virus replication and
for its opposite capacities to regulate apoptosis, a property that
strongly depends on the cellular context and stimulus (Bours et al.,
2000; Ludwig and Planz, 2008; Wurzer et al., 2004). Reporter gene
analysis revealed that NF-κB activity was raised 3.2- and 4-fold
upon infection of MEF Cav-1 (/) and MEF WT with H1N1
inﬂuenza virus, respectively. However, to gain deeper insight into
NF-κB-mediated mechanisms, a plethora of further experiments
could be necessary.
The degree of the type I interferon response limits IAV multi-
plication, because of the expression of antiviral genes (Mx, PKR,
OAse, IFITM, viperin). In the absence of a functional IFN response,
IAV replication has considerably raised in mouse cell lines (Garcia-
Sastre et al., 1998). Obviously, the resistance genes involved in the
type I interferon response are slightly suppressed in infected MEF
Cav-1 (/) (as indicated by the absence of ISRE-mediated
expression). This suggests that an insufﬁcient interferon type I
response may contribute to the increase in viral replication.
Conclusion
We have found that Cav-1, a multifaceted membrane protein,
negatively regulates IAV multiplication in MEFs, as depletion of
Cav-1 causes an increase of infectious virus production of more
than two orders of magnitude. Most prominently, ROS formation is
strongly induced, and the course of apoptosis is altered in infected
Cav-1-deﬁcient MEFs. Interestingly, both processes have been
previously associated with efﬁcient inﬂuenza virus propagation
in A549 lung cells, suggesting that (un)favorable conditions for
virus replication can be established by the expression or deletion
of certain cellular genes. In our investigation, Cav-1 clearly serves
as a sentinel in MEFs, prohibiting inﬂuenza virus from exploiting
these intra-cellular mechanisms. Presently, whether Cav-1 is just a
regulator of pathways supporting (impairing) virus multiplication
or even represents a new cellular restriction factor present in
mouse ﬁbroblast that interferes with an inﬂuenza virus protein by
binding remains unclear. Identiﬁcation of the cellular co-factors or
a putative interaction of Cav-1 with a viral virulence factor in MEFs
should help to clarify this issue.
Implications of the results
The production of inﬂuenza virus vaccines, traditionally per-
formed in embryonated hen eggs, will shift, to an increasing degree,
to cell lines as new cell factories for vaccine raw products (e.g.,
MDCK or duck suspension cell lines). An inﬂuenza-virus-based
subunit vaccine produced in MDCK cells grown in suspension was
approved in 2012 by the FDA. Other systems originating from duck
cells, e.g., Age CR (Probiogen, Germany) or EB66 (Vivalis, France),
are successfully used for virus production (Brown and Mehtali,
2010; Lohr et al., 2009; Olivier et al., 2010). Because of the cost
reduction by a decrease in medium consumption and simpliﬁed
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downstream processing, systems that provide high particle titers
are preferred. Thus, a titer increase caused by Cav-1 loss might be a
valuable discovery in developing systems for the high-titer produc-
tion of virus vaccines. Interestingly, recent results support such a
view. For example, among 13 cell lines compared in the replication
efﬁciency of various inﬂuenza viruses, Caco-2, a colorectal cancer
cell line lacking Cav-1 expression, was among the best virus
producers (Li et al., 2009). Furthermore, while screening non-
epithelial avian cell lines for their potential to support high-level
inﬂuenza virus production, we noticed that those ﬁbroblast cells
expressing Cav-1 exhibited considerably lower titers upon H1N1
infection when compared with avian cell lines lacking Cav-1 (data
not published). Based on these results, a new suspension cell line,
sEFB-1, has been developed, which is devoid of Cav-1 expression,
and which is suitable for the high-titer production of human
inﬂuenza viruses (WO 2013/164389).
Material and methods
Cell lines and cell culture
The MEF cell lines were supplied by ATCC (CRL 2572 and
CRL2573 and designated 3T3 MEF WT and 3T3 MEF Cav-1 (/)
or 3T3 MEF KO, respectively) and cultivated in DMEM supplemen-
ted with 10% fetal bovine serum, 2 mM glutamine, and 100 U/ml
penicillin/100 mg/ml streptomycin incubated at 37 1C and 5% CO2.
Cells were passaged before conﬂuence.
Virus and virus assays
Infections were performed with human inﬂuenza A/PR/8/1934
virus (Mount Sinai strain) kindly provided by Stephan Ludwig
(Inst. Virology, University of Munster, Germany) as described
previously (Sun et al., 2010). For determination of the infectious
virus titers, plaque assays were performed on MDCK cells as
previously reported (Sun et al., 2010). Viral particle numbers
were determined by using a luminometric neuraminidase assay
(NA STAR, Applied Biosystems) as detailed in the manual from the
supplier.
Plasmids and transfections
Retroviral RNAi vectors pRVH1Cav-1 and pRVH1 were obtained
from Kai Simons (MPI, Dresden, Germany). Retroviral transduc-
tions were performed as described previously (Schuck et al.,
2004). Selection for Cav-1 knock-down pools of cells from trans-
duced MEF and A549 was performed with 1.5 mg/ml puromycin.
pCav1 WT was obtained from Michael Quon and contains
dog Cav-1 cDNA under the control of a CMV-IE-based promoter
(Nystrom et al., 1999). Transient transfections were performed with
Lipofectamine 2000 and optimized as suggested by the supplier.
Transfection efﬁciencies were determined in co-transfections with
enhanced green ﬂuorescent protein or luciferase expression plas-
mids or directly by Western blot analysis as described earlier
(Sun et al., 2010). For a list of plasmids used in the Cignal 45 array
(SA Biosciences) including spotted transcriptional regulatory
elements, the homepage of the supplier is recommended.
Cignal ﬁnder 45-pathway reporter gene array
The gene array is a cell-based reporter array for identifying
multiple signaling pathways in cultured cells by monitoring the
activity of 45 transcription factors. 45er arrays were performed
in the 96-well plate format as recommended by the supplier
(SA Biosciences, now Qiagen) in three independent experiments
for each dataset. Each array contains 45 expression plasmids
spotted in duplicate. Each plasmid harbors an individual transcrip-
tion factor binding site in front of a minimal promoter and a ﬁreﬂy
luciferase reporter and indicates the activity status of the respec-
tive signal transduction pathway. The wells also contain a Renilla
luciferase reporter, which serves to equalize the differences in
transfection efﬁciency. Seperately, positive (with a constitutive
promoter) and negative control vectors and an EGFP transfection
control vector are included. Comparisons were performed for
mock-infected (KO/WT) and PR8-infected cell lines (KO i/KO; WT
i/WT) and between both infected cell lines (KO i/WT i). Brieﬂy, the
reverse transfection procedure was applied by using 1.5 ml Lipo-
fectamine 2000 (Invitrogen) in 50 ml OptiMEM per well and DNA
for an incubation time of 20 min at room temperature. Thereafter,
equal cell numbers of MEF WT and MEF Cav-1 (/) were seeded
onto the plates and incubated for 1 day at 37 1C. A medium
exchange after 1 day was followed by a further 1-day incubation.
When cells were to be infected, infections with IAV were per-
formed as described previously with an MOI of 0.5 at 2 days after
reverse transfection for a period of 5 h. Gene expression was
analyzed from lysed cells after the relevant time in an LB96P
microplate luminometer (Berthold) with the help of the Dual
Luciferase Reporter assay following the recommendations of the
supplier. Evaluation of the datasets was performed with the
suppliers software package (SA Biosciences). For statistical evalua-
tion, standard errors were calculated, and results were compared
as recently suggested (Cumming et al., 2007). Statistical evalu-
ation of the control datasets showed that a 1.7-fold increase of
average values upon stimulus was sufﬁcient to give a p-value of
o0.05. Individual p-values were derived from unpaired t-tests
(SigmaPlot).
Detection and quantiﬁcation of ROS and glutathione
At 24 h after infection, CellROX Deep Red reagent (Invitrogen)
was added directly to the cells and incubated for 30 min at 37 1C.
Cells were washed with PBS and stained for another 30 min with
Hoechst 33342. Fluorescence was monitored with Zeiss Axiovert
(RFPXF11: BP530-585, FT 600, LP 615 and BFP ﬁlter) and quantiﬁed
by using Image J and an automated counting procedure. Alterna-
tively, CellROX Orange (Invitrogen) was used and processed as
recommended by the supplier.
Glutathione and oxidized glutathione levels were determined
by using the luminometric GSH/GSSG Glo assay (Promega) as
detailed in the manual of the supplier.
Apoptosis assays
For programmed cell death, the Annexin V FlUOS staining kit
(Roche diagnostics), the pSIVA-IANBD Kit (Biomol, Imgenex) or the
Cell Event Caspase 3/7 Green Detection Reagent were applied
following the recommendations of the suppliers.
Annexin-V-FlUOS: Cells were seeded on 8-well chamber slides
(Nunc) and infected 1 day later with inﬂuenza virus. After 16 h, the
medium was exchanged with Annexin V labeling solution for
15 min followed by Hoechst 33342 staining for the visualization
of cell nuclei. Cells were observed by using a Zeiss Axiovert 135 TV
(BFP and GFP ﬁlters, Omega Optical), and digital photographs were
analyzed by using Image J or Image Pro AMS 6.1. The percentage of
positive cells was determined by an automated image analysis as
detailed the software manuals.
Caspase 3/7 assay: Caspase-3/7 Green Detection Reagent was
added at 6, 16, and 24 h after infection of cells that were seeded
on 8-well chamber slides for 30 min, followed by staining with
Hoechst 33342, subsequent microscopic inspection, and image
analysis.
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Inhibition assays
Inhibitors were pre-incubated 1 h before infection and were
maintained in the incubation period after infection. ROS was
inhibited by the addition of 0.1 or 1 mM N-Acetyl-cysteine (NAC,
Sigma-Aldrich).
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